Separate names with a comma.
ARMO Biosciences loss in the fiscal year 2017 has increased compared to the fiscal year 2016. I don't know why Lilly is acquiring this loss making...
Lilly signs a deal with Germany-based Curevac to strengthen its oncology division. http://alph.st/b72eaf5f
Is this deal advantageous for Celgene? BeiGene (ADR) has surged nearly 28% as of now.